Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-001864-50Phase 4Completed
Phase 4 trial of Boostrix Polio in pertussis (2 arms), sponsored by National Institute for Public Health and the Environment. Primary endpoint: Pertussis-specific immune response before and after booster vaccination. Started May 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-001864-50.